Mounjaro side effects in females: what the evidence says

Which side effects do women most often notice on Mounjaro?

The side-effect profile of tirzepatide is broadly the same across sexes, but the experience of starting a GLP-1 and GIP dual agonist can feel very different in practice. Nausea tops the list, followed by loose stools, constipation, burping, reflux and occasional vomiting. Fatigue and headache are also common in the first few weeks, particularly after moving to a new dose. The NHS tirzepatide medicines page sets these out clearly and is worth bookmarking.

Most women find the GI symptoms are sharpest in the 24–48 hours after an injection, then fade. Eating smaller portions, staying well hydrated and avoiding very fatty or spicy foods in the first days at a new dose tends to help. A question our prescribers hear most weeks is whether the nausea ever goes away entirely, for the majority, yes, it does settle as the body acclimatises, though it may briefly return at each dose increase.

Injection-site reactions, redness or mild bruising around the abdomen, thigh or upper arm, are also reported. Rotating the site each week reduces this. Dizziness on standing can occur, especially in women who are eating significantly less and not drinking enough water, it is worth flagging to your prescriber if it happens regularly.

Are there side effects that affect women specifically?

Two concerns come up consistently in female patients: contraception and hair loss. Both deserve a straight answer.

On contraception: because tirzepatide slows gastric emptying, it can temporarily reduce absorption of oral contraceptive pills. NHS England's guidance on weight-management injections advises adding a non-oral contraceptive method, such as condoms, for the first four weeks of treatment and for four weeks after any dose increase. This applies to tirzepatide specifically; current evidence does not show the same effect with semaglutide. Women using HRT should discuss with their prescriber whether a transdermal form (patch or gel) is preferable while on tirzepatide, for the same absorption reason.

On hair loss: some women notice increased shedding, typically starting two to four months into treatment. This is almost always telogen effluvium, a temporary pause in the hair growth cycle triggered by rapid weight loss and reduced calorie intake, not by tirzepatide itself. It tends to resolve on its own. If you want to understand what is happening and what, if anything, can be done about it, our pages on whether Mounjaro causes hair loss in females and managing hair loss on Mounjaro cover it in detail.

Mood changes are another topic women raise. The evidence is nuanced, some people report low mood or irritability, particularly early on. If you notice significant changes, speak to your prescriber; our page on whether Mounjaro affects mood covers what is currently known.

When should a woman seek urgent medical help?

Most side effects are uncomfortable rather than dangerous, but a few warrant prompt attention. Seek medical help without delay if you experience severe, persistent abdominal pain that radiates to your back, with or without vomiting, this can be a sign of acute pancreatitis. In January 2026 the MHRA issued a Drug Safety Update confirming acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines; the MHRA Drug Safety Update is the primary reference for this.

Other urgent symptoms include signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing, or a widespread rash), severe vomiting or diarrhoea leading to dehydration, gallbladder pain (sharp pain in the upper right abdomen, sometimes with fever or jaundice), and any sudden change in vision. Contact 999 or your nearest emergency department for these.

If you experience any unexpected or worrying symptom, report it through the Yellow Card scheme at yellowcard.mhra.gov.uk, patient reports contribute to the ongoing safety monitoring of tirzepatide.

Tirzepatide is not recommended during pregnancy, while breastfeeding, or when actively trying to conceive. It is also not licensed for anyone under 18. Women who become pregnant while on treatment should stop immediately and contact their GP.

How does nume approach side effects before and during treatment?

Mounjaro is a prescription-only medicine, and UK law requires a clinical assessment before any prescriber can authorise it. At nume, that assessment is carried out personally by a GPhC-registered Independent Prescriber who reviews the full consultation (health history, current medicines, contraceptive method) before approving treatment. Side effects, including the female-specific ones covered here, are part of what that review addresses.

If you have questions once treatment has started, our prescribers are available for aftercare seven days a week. The full Mounjaro side effects guide covers the complete profile, and our page on side effects in males provides a useful comparison. For a broader picture of what tirzepatide involves, the Mounjaro overview is the place to start. To discuss your own situation with a prescriber, start your free consultation.